Medication info

Barozet Tablet 10/20 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Anguk New Pharm Co., Ltd.
Appearance
White to pale yellow, double-convex, rectangular tablet
Packaging
30 tablets (10 tablets/PTP × 3)
Approval status
Expired

MFDS item code 201901143 · Approved 2019.02.22

This product's status changed to Expired on 2024.02.22. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dosage of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range for this drug is 10/10mg to 10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10mg once daily. After starting this drug or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have been taking this drug at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This drug is used as an adjunct to other lipid-lowering therapy (e.g., LDL apheresis) or when other lipid-lowering therapies are not useful. Administration to patients with hepatic impairment No dosage adjustment is necessary for patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 4. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). Patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡ should receive 10/20mg of this drug once daily in the evening. When administering higher doses of this drug to these patients, use caution and monitor them closely (see Precautions for Use, 4. General Precautions). Administration to elderly patients No dosage adjustment is necessary in elderly patients. Concomitant administration with other drugs (See Precautions for Use, 5. Interactions.) This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Ingredients

Manufacturer
Anguk New Pharm Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This medicine is used alongside dietary therapy in patients with primary hypercholesterolemia and mixed hyperlipidemia to reduce elevated total cholesterol, LDL-cholesterol, apolipoprotein B, and triglycerides, and to increase good cholesterol, HDL-cholesterol. Additionally, in patients with homozygous familial hypercholesterolemia, this medication can be used as an adjunct to other therapies, or it may be used alone if other treatments are ineffective. This medication helps lower the risk of atherosclerotic vascular disease due to hypercholesterolemia and is appropriate when dietary and non-drug therapies are insufficient. It is important to confirm the causes of secondary dyslipidemia before administration and treat the underlying causes if necessary. Lipid tests should be done to help establish an adequate treatment plan considering multiple lipid parameters. Thus, this medication is effective in improving hypercholesterolemia and related lipid abnormalities.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dosage of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This drug is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range for this drug is 10/10mg to 10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10mg once daily. After starting this drug or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have been taking this drug at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily, administered in the evening. This drug is used as an adjunct to other lipid-lowering therapy (e.g., LDL apheresis) or when other lipid-lowering therapies are not useful. Administration to patients with hepatic impairment No dosage adjustment is necessary for patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see Precautions for Use, 4. General Precautions, Patients with Abnormal Liver Function). Administration to patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). Patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡ should receive 10/20mg of this drug once daily in the evening. When administering higher doses of this drug to these patients, use caution and monitor them closely (see Precautions for Use, 4. General Precautions). Administration to elderly patients No dosage adjustment is necessary in elderly patients. Concomitant administration with other drugs (See Precautions for Use, 5. Interactions.) This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Precautions

This medicine is used to lower cholesterol levels. However, it can cause muscle-related issues, with symptoms such as muscle pain or weakness. In particular, there is a risk of rare side effects like rhabdomyolysis, which involves severe muscle damage, so caution is required. If experiencing muscle pain, tenderness, or weakness while taking this medication, you should inform your doctor immediately. Also, this medication may affect liver function, so it is not recommended for patients with liver disease or elevated liver enzyme levels. Women who are pregnant or nursing should not take this medication, and women who may become pregnant should consult a doctor before use. The risk of muscle damage can increase when taken with certain drugs, so you must inform your doctor if you are on other medications. Caution is especially needed when used with drugs that inhibit enzymes that metabolize drugs in the liver, certain antibiotics, antiviral drugs, or immunosuppressants. Elderly patients or those with reduced kidney function also have a higher risk of muscle problems while taking this medication, necessitating careful monitoring. It is recommended to regularly check liver function and muscle condition through blood tests while using this medication. There is no specific antidote for overdose, so if overdosed, immediate medical treatment is necessary. Finally, it is advisable to avoid excessive consumption of grapefruit juice while taking this medication, as it can increase the drug's concentration in the blood and elevate the risk of side effects.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 95 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • immune-mediated necrotizing myopathy
  • taste disturbance
  • extraocular movement disorders
  • facial weakness
  • tremor
  • dizziness
  • sensory disturbances
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • depression
  • cognitive impairment
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • pancreatitis
  • hepatitis
  • cholestatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • liver failure
  • loss of appetite
  • vomiting
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GT
  • increased bilirubin level
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • elevated fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature to ensure the drug's effects and safety remain intact over time.

Appearance and packaging

Appearance

White to pale yellow, double-convex, rectangular tablet

Package unit

30 tablets (10 tablets/PTP × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.